MercyOne Genesis Davenport Medical Center — Davenport, Iowa

MercyOne Genesis Davenport Medical Center is a clinical research site located in Davenport, Iowa, United States 52803.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

MercyOne Genesis Davenport Medical Center has participated in 27 clinical trials with 23 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Davenport

Browse all research sites in Iowa · View every site in Davenport

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MercyOne Genesis Davenport Medical Center?

MercyOne Genesis Davenport Medical Center has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MercyOne Genesis Davenport Medical Center conducted?

MercyOne Genesis Davenport Medical Center has 27 clinical trials on record, with 23 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is MercyOne Genesis Davenport Medical Center accredited by Crixeo Clinical Trials?

MercyOne Genesis Davenport Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MercyOne Genesis Davenport Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.